Adamis Pharma Alpha and Beta Analysis
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Adamis Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Adamis Pharma over a specified time horizon. Remember, high Adamis Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Adamis Pharma's market risk premium analysis include:
Beta 2.61 | Alpha (2.11) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Adamis |
Adamis Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Adamis Pharma market risk premium is the additional return an investor will receive from holding Adamis Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Adamis Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Adamis Pharma's performance over market.| α | -2.11 | β | 2.61 |
Adamis Pharma Fundamentals Vs Peers
Comparing Adamis Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Adamis Pharma's direct or indirect competition across all of the common fundamentals between Adamis Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Adamis Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Adamis Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Adamis Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Adamis Pharma to competition |
| Fundamentals | Adamis Pharma | Peer Average |
| Return On Equity | -7.85 | -0.31 |
| Return On Asset | -1.04 | -0.14 |
| Operating Margin | (3.74) % | (5.51) % |
| Current Valuation | 7.28 M | 16.62 B |
| Shares Outstanding | 9.36 M | 571.82 M |
| Shares Owned By Insiders | 7.81 % | 10.09 % |
| Shares Owned By Institutions | 16.59 % | 39.21 % |
Adamis Pharma Opportunities
Adamis Pharma Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Adamis Q1 Earnings Snapshot | 05/15/2023 |
2 | Acquisition by Versi Ebrahim of 8745 shares of Adamis Pharma subject to Rule 16b-3 | 05/30/2023 |
3 | Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention | 06/22/2023 |
4 | Tasso, United BioSource partner to improve sample collection - FierceBiotech | 07/05/2023 |
About Adamis Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Adamis or other delisted stocks. Alpha measures the amount that position in Adamis Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Adamis Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Adamis Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Adamis Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Adamis Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Adamis Pharma. Please utilize our Beneish M Score to check the likelihood of Adamis Pharma's management manipulating its earnings.
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Build Portfolio with Adamis Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |